4-[4-(4-Fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-3-butyn-1-ol
| 215303-72-3 Basic information More.. |
Product Name: | 4-[4-(4-Fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-3-butyn-1-ol | Synonyms: | 4-[4-(4-Fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-3-butyn-1-ol;RWJ 67657;4-(4-Fluorophenyl)-2-(4-hydroxy-1-butynyl)-1-(3-phenylpropyl)-5-(4-Pyridyl)iMidazole;JNJ 3026582;RWJ-67657;JNJ-3026582;CS-1470;RWJ-67657; RWJ-67657; RWJ-67657;3-Butyn-1-ol, 4-[4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]- | CAS: | 215303-72-3 | MF: | C27H24FN3O | MW: | 425.5 | EINECS: | | Mol File: | 215303-72-3.mol | ![215303-72-3](/CAS/GIF/215303-72-3.gif) |
Use
RWJ-67657 is a p38 mitogen-activated protein-kinase (p38MAPK) inhibitor. Studies show that RWJ-67657 might provide a useful tool to intervene in the deranged immune response in sepsis and other inflam
matory diseases. RWJ 67657 has been shown to inhibit chemokine production and E-selectin expression in activated endothelial cells,
|
215303-72-3
Recommend Suppliers |
|
Tag:
215303-72-3
|